Tolerability and quality of life in ARB-treated patients

American Journal of Managed Care

Volumn 11, Issue SUPPL. 13, 2005, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN HEXETIL; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; LOSARTAN; VALSARTAN;

ANGIONEUROTIC EDEMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSS REACTION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG TOLERABILITY; EDEMA; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; NAUSEA; NOCTURIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; SIDE EFFECT;

ANTIHYPERTENSIVE AGENTS; COUGH; DIZZINESS; HEADACHE; HUMANS; HYPERTENSION; PATIENT COMPLIANCE; QUALITY OF LIFE; RECEPTORS, ANGIOTENSIN; TREATMENT OUTCOME;

EID: 28344443071     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (23)

1. Conlin PR, Spence JD, Williams B, et al. Angiotensin II antagonists for hypertension: are there differences in efficacy? Am J Hypertens. 2000;13(4 pt 1):418-426.
2. Stephenson J. Noncompliance may cause half of anti-hypertensive drug "failures." JAMA. 1999;282:313-314.
3. Hunt SM. Quality of life claims in trials of anti-hypertensive therapy. Qual Life Res. 1997;6:185-191.
4. See S, Stirling AL. Candesartan cilexetil: an angiotensin II-receptor blocker. Am J Health Syst Pharm. 2000;57:739-746.
5. Benz J, Oshrain C, Henry D, Avery C, Chiang YT, Gatlin M. Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide. J Clin Pharmacol. 1997;37:101-107.
6. Lacourciere Y. The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group. Int J Clin Pract. 1999;53:99-103,
7. Lacourciere Y, Brunner H, Irwin R, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. J Hypertens, 1994;12:1387-1393.
8. Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1893-1906.
9. Wu SC, Liu CP, Chiang HT, Lin SL. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients. Heart Vessels. 2004;19:13-18.
10. Prisant LM. Angioneurotic edema. J Clin Hypertens (Greenwich). 2001;3:262-263.
11. Sica DA, Black HR. Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy. Congest Heart Fail. 2002;8:334-341, 345.
12. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf. 1998;18:171-188.
13. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angioedema. Lancet. 1998;351:1693-1697.
14. Gavras I, Gavras H. Are patients who develop angioedema with ACE inhibition at risk of the same problem with AT1 receptor blockers? Arch Intern Med. 2003;163:240-241.
15. Irons BK, Kumar A. Valsartan-induced angioedema. Ann Pharmacother. 2003;37:1024-1027.
16. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med. 2004;164:910-913.
17. Howes LG, Tran D. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf. 2002;25:73-76.
18. Hernandez-Hernandez R, Sosa-Canache B, Velasco M, Armas-Hernandez MJ, Armas-Padilla MC, Cammarata R. Angiotensin II receptor antagonists role in arterial hypertension. J Hum Hypertens. 2002;16(suppl 1):S93-S99.
19. Grossman E, Messerli FH, Neutel JM. Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors? Arch Intern Med. 2000;160:1905-1911.
20. Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacother. 2000;34:526-528.
21. Thaker D, Frech F, Gil M. Adverse event reporting of ACEI and ARB associated angioedema. Am J Hypertens. 2005;18(5 suppl 1):A116.
22. Yamamoto S, Kawashima T, Kunitake T, Koide S, Fujimoto H. The effects of replacing dihydropyridine calcium-channel blockers with angiotensin II receptor blocker on the quality of life of hypertensive patients. Blood Press Suppl. 2003;2:22-28.
23. Goodman R, Lanese J, Singson C, et al. Symptom assessment and quality of life in hypertensive patients following modification of antihypertensive therapy to a regimen containing valsartan. J Clin Outcomes Res. 2004;8:1-14.